• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣综合征患者的心脏肥大及相关功能障碍——文献综述

Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients-Literature Review.

作者信息

Kanzaki Akinori, Kadoya Manabu, Katayama Satoru, Koyama Hidenori

机构信息

Department of Internal Medicine, Hyogo College of Medicine, Sasayama Medical Center, Sasayama 669-2321, Hyogo, Japan.

Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya 663-8131, Hyogo, Japan.

出版信息

J Clin Med. 2022 Nov 28;11(23):7035. doi: 10.3390/jcm11237035.

DOI:10.3390/jcm11237035
PMID:36498610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9739690/
Abstract

The survival rate of adrenal Cushing syndrome patients has been greatly increased because of the availability of appropriate surgical and pharmacological treatments. Nevertheless, increased possibility of a heart attack induced by a cardiovascular event remains a major risk factor for the survival of affected patients. In experimental studies, hypercortisolemia has been found to cause cardiomyocyte hypertrophy via glucocorticoid receptor activation, including the possibility of cross talk among several hypertrophy signals related to cardiomyocytes and tissue-dependent regulation of 11β-hydroxysteroid dehydrogenase type 1. However, the factors are more complex in clinical cases, as both geometric and functional impairments leading to heart failure have been revealed, and their associations with a wide range of factors such as hypertension are crucial. In addition, knowledge regarding such alterations in autonomous cortisol secretion, which has a high risk of leading to heart attack as well as overt Cushing syndrome, is quite limited. When considering the effects of treatment, partial improvement of structural alterations is expected, while functional disorders are controversial. Therefore, whether the normalization of excess cortisol attenuates the risk related to cardiac hypertrophy has yet to be fully elucidated.

摘要

由于有了合适的手术和药物治疗方法,肾上腺库欣综合征患者的存活率大幅提高。然而,心血管事件引发心脏病发作的可能性增加仍然是影响患者存活的主要风险因素。在实验研究中,已发现高皮质醇血症通过糖皮质激素受体激活导致心肌细胞肥大,包括几种与心肌细胞相关的肥大信号之间存在相互作用以及11β - 羟类固醇脱氢酶1型的组织依赖性调节的可能性。然而,临床病例中的因素更为复杂,因为已揭示出导致心力衰竭的几何和功能损伤,并且它们与高血压等多种因素的关联至关重要。此外,关于自主性皮质醇分泌这种改变(其导致心脏病发作以及明显库欣综合征的风险很高)的知识相当有限。在考虑治疗效果时,预计结构改变会部分改善,而功能障碍则存在争议。因此,过量皮质醇的正常化是否能降低与心肌肥大相关的风险尚未完全阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/9739690/74523ede51a5/jcm-11-07035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/9739690/a8813a745dc6/jcm-11-07035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/9739690/74523ede51a5/jcm-11-07035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/9739690/a8813a745dc6/jcm-11-07035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f1/9739690/74523ede51a5/jcm-11-07035-g002.jpg

相似文献

1
Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients-Literature Review.库欣综合征患者的心脏肥大及相关功能障碍——文献综述
J Clin Med. 2022 Nov 28;11(23):7035. doi: 10.3390/jcm11237035.
2
Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.皮质类固醇与α-肾上腺素能信号之间的相互作用增强心肌细胞肥大:血清/糖皮质激素调节激酶1的潜在作用。
Cardiovasc Res. 2006 Jun 1;70(3):555-65. doi: 10.1016/j.cardiores.2006.02.010. Epub 2006 Feb 14.
3
Cushing syndrome as a failed cardiac screen in a patient with McCune-Albright syndrome: a case report.库欣综合征作为一名患有 McCune-Albright 综合征患者的心脏筛查失败病例:一例报告。
J Med Case Rep. 2022 Sep 15;16(1):342. doi: 10.1186/s13256-022-03533-1.
4
11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy.11β-羟类固醇脱氢酶 1 型抑制剂可减轻高脂饮食诱导的心肌病。
J Mol Cell Cardiol. 2018 Dec;125:106-116. doi: 10.1016/j.yjmcc.2018.10.002. Epub 2018 Oct 3.
5
Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.组织特异性库欣综合征、11β-羟类固醇脱氢酶与皮质类固醇激素作用的重新定义
Eur J Endocrinol. 2003 Sep;149(3):163-8. doi: 10.1530/eje.0.1490163.
6
Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.代谢综合征是一种细胞内库欣状态吗?多种体液因子对肝脏糖皮质激素激活酶(11β-羟类固醇脱氢酶1型)基因转录活性的影响。
Mol Cell Endocrinol. 2008 Mar 26;285(1-2):10-8. doi: 10.1016/j.mce.2008.01.012. Epub 2008 Feb 2.
7
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.异位促肾上腺皮质激素(ACTH)分泌所致库欣综合征伴高血压和低钾血症:58例病例系列研究
Ann N Y Acad Sci. 2002 Sep;970:134-44. doi: 10.1111/j.1749-6632.2002.tb04419.x.
8
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy.糖皮质激素信号失调在病理性心脏肥大中的作用的新见解。
Heart Fail Rev. 2022 Jul;27(4):1431-1441. doi: 10.1007/s10741-021-10158-x. Epub 2021 Aug 28.
9
Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol.库欣综合征患者肾上腺皮质腺瘤中促肾上腺皮质激素受体基因的表达:对皮质醇自主分泌的可能作用。
Ann Surg. 2001 Jul;234(1):85-91. doi: 10.1097/00000658-200107000-00013.
10
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.11β-羟化酶 1 是调节循环糖皮质激素过多的组织特异性效应的主要调节因子。
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2482-91. doi: 10.1073/pnas.1323681111. Epub 2014 Jun 2.

引用本文的文献

1
The impact of hypercortisolism beyond metabolic syndrome on left ventricular performance: a myocardial work analysis.皮质醇增多症超出代谢综合征对左心室功能的影响:心肌做功分析
Cardiovasc Diabetol. 2025 Mar 21;24(1):132. doi: 10.1186/s12933-025-02680-1.
2
Association Between Longitudinal Changes in Left Ventricular Structure and Function and 24-Hour Urinary Free Cortisol in Essential Hypertension.原发性高血压患者左心室结构和功能的纵向变化与24小时尿游离皮质醇之间的关联
J Clin Hypertens (Greenwich). 2025 Feb;27(2):e14979. doi: 10.1111/jch.14979.
3
Epicardial adipose tissue volume highly correlates with left ventricular diastolic dysfunction in endogenous Cushing's syndrome.

本文引用的文献

1
Tissue-specific regulation of 11β hydroxysteroid dehydrogenase type-1 mRNA expressions in Cushing's syndrome mouse model.库欣综合征小鼠模型中 11β 羟甾类脱氢酶-1 mRNA 表达的组织特异性调节。
Steroids. 2022 Jul;183:109021. doi: 10.1016/j.steroids.2022.109021. Epub 2022 Mar 23.
2
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside.轻度皮质醇增多症的病理生理学:从实验室到临床。
Int J Mol Sci. 2022 Jan 8;23(2):673. doi: 10.3390/ijms23020673.
3
Cardiovascular complications of mild autonomous cortisol secretion.轻度自主皮质醇分泌的心血管并发症。
心外膜脂肪组织体积与内源性库欣综合征患者的左心室舒张功能障碍高度相关。
Ann Med. 2024 Dec;56(1):2387302. doi: 10.1080/07853890.2024.2387302. Epub 2024 Aug 5.
4
Cardiac magnetic resonance reveals biventricular impairment in Cushing's syndrome: a multicentre case-control study.心脏磁共振显示库欣综合征患者双心室功能障碍:一项多中心病例对照研究。
Endocrine. 2024 Aug;85(2):937-946. doi: 10.1007/s12020-024-03856-7. Epub 2024 May 22.
5
Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids.使用人诱导多能干细胞衍生的多细胞心脏类器官模拟急性心肌梗死和心脏纤维化。
Cell Death Dis. 2024 May 1;15(5):308. doi: 10.1038/s41419-024-06703-9.
6
Cushing's syndrome presenting as non-atherosclerotic myocardial infarction and heart failure.库欣综合征表现为非动脉粥样硬化性心肌梗死和心力衰竭。
ESC Heart Fail. 2023 Dec;10(6):3714-3717. doi: 10.1002/ehf2.14548. Epub 2023 Oct 18.
Best Pract Res Clin Endocrinol Metab. 2021 Mar;35(2):101494. doi: 10.1016/j.beem.2021.101494. Epub 2021 Feb 23.
4
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.产前皮质类固醇用于加速有早产风险的孕妇的胎儿肺成熟。
Cochrane Database Syst Rev. 2020 Dec 25;12(12):CD004454. doi: 10.1002/14651858.CD004454.pub4.
5
Epidemiology and Comorbidity of Adrenal Cushing Syndrome: A Nationwide Cohort Study.肾上腺库欣综合征的流行病学和合并症:一项全国性队列研究。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1362-e1372. doi: 10.1210/clinem/dgaa752.
6
Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study.代谢紊乱患者心脏自主神经功能和舒张功能的亚临床下降:HSCAA研究
Metabol Open. 2020 Jan 22;5:100025. doi: 10.1016/j.metop.2020.100025. eCollection 2020 Mar.
7
Mortality of Patients with Cushing's Disease.库欣病患者的死亡率。
Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):203-207. doi: 10.1055/a-1197-6380. Epub 2020 Jul 9.
8
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications.库欣综合征:临床表现、诊断工具和并发症概述。
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101380. doi: 10.1016/j.beem.2020.101380. Epub 2020 Jan 30.
9
Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study.库欣综合征中的高凝状态、血栓形成事件的患病率:一项大型单中心回顾性研究。
J Endocr Soc. 2019 Dec 15;4(2):bvz033. doi: 10.1210/jendso/bvz033. eCollection 2020 Feb 1.
10
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome.库欣综合征患者高血压的病理生理学与治疗
Front Endocrinol (Lausanne). 2019 May 21;10:321. doi: 10.3389/fendo.2019.00321. eCollection 2019.